Center for Health Promotion and Disease Prevention, Arizona State University, Phoenix, Arizona, USA.
College of Health Solutions, Arizona State University, Phoenix, Arizona, USA.
Pediatr Obes. 2022 Apr;17(4):e12867. doi: 10.1111/ijpo.12867. Epub 2021 Nov 3.
Glucose concentrations during an oral glucose tolerance test (OGTT) have been used as biomarkers to differentiate type 2 diabetes risk phenotypes. No studies have examined changes in OGTT-glucose phenotypes following lifestyle intervention among high-risk youth.
To examine changes in OGTT-glucose phenotypes following lifestyle intervention and to explore differences in insulin sensitivity and β-cell function among post-intervention phenotypes.
Latino adolescents with obesity (n = 48, age 15.4 ± 1.0, BMI% 98.2 ± 1.4, female 56.3%) completed a 12-week lifestyle intervention that included weekly nutrition education and physical activity. At baseline and 12 weeks, youth completed a 2-h OGTT with glucose and insulin concentrations assessed at 0', 30', 60', 90' and 120'. Glucose concentrations during the OGTT were used to identify biomarkers, 1-h glucose, glucose response curve and time to glucose peak. Using these respective biomarkers, high-risk (1-h glucose ≥ 155 mg/dl, Monophasic, Late Peak) and lower-risk phenotypes (1-h glucose < 155 mg/dl, Biphasic, Early Peak) were categorized. Insulin sensitivity was estimated by whole-body insulin sensitivity index (WBISI) and β-cell function by oral disposition index (oDI).
Following intervention, the prevalence of Monophasic phenotypes decreased from 81% to 67% (p = 0.048) and 1-h glucose ≥ 155 mg/dl from 38% to 10% (p = 0.054). Although Late Peak phenotypes did not significantly change (from 58% to 29%, p = 0.200), Early Peak phenotypes at post-intervention demonstrated significantly higher WBISI compared to Late Peak (2.3 ± 0.1 vs 1.7 ± 0.2, p = 0.023).
OGTT-glucose phenotypes improve following lifestyle intervention among high-risk youth. These findings further support their potential utility as clinical biomarkers to identify diabetes risk and risk reduction in youth.
口服葡萄糖耐量试验(OGTT)期间的血糖浓度已被用作区分 2 型糖尿病风险表型的生物标志物。尚无研究探讨生活方式干预后高风险青少年 OGTT 葡萄糖表型的变化。
研究生活方式干预后 OGTT 葡萄糖表型的变化,并探讨干预后各表型之间胰岛素敏感性和β细胞功能的差异。
48 名肥胖的拉丁裔青少年(年龄 15.4 ± 1.0 岁,BMI% 98.2 ± 1.4%,女性占 56.3%)完成了一项为期 12 周的生活方式干预,包括每周营养教育和体育活动。在基线和 12 周时,青少年进行了 2 小时 OGTT,检测 0'、30'、60'、90'和 120'时的血糖和胰岛素浓度。使用这些相应的生物标志物,确定高风险(1 小时血糖≥155mg/dl,单相,晚峰)和低风险表型(1 小时血糖<155mg/dl,双相,早峰)。胰岛素敏感性通过全身胰岛素敏感性指数(WBISI)估计,β细胞功能通过口服处置指数(oDI)估计。
干预后,单相表型的患病率从 81%降至 67%(p=0.048),1 小时血糖≥155mg/dl 的比例从 38%降至 10%(p=0.054)。尽管晚峰表型没有显著变化(从 58%降至 29%,p=0.200),但干预后早峰表型的 WBISI 显著高于晚峰表型(2.3±0.1 比 1.7±0.2,p=0.023)。
高危青少年生活方式干预后 OGTT 葡萄糖表型改善。这些发现进一步支持了它们作为临床生物标志物的潜在效用,可用于识别青少年的糖尿病风险和降低风险。